
Supporting NHS England’s consultation on low-value medicines
Home » Case studies » Supporting NHS England’s consultation on low-value medicines
In 2017, NHS England sought public and patient input on proposals to limit the prescribing of 18 products considered low-value for routine NHS primary care prescriptions. Our communications, engagement, and medicines management teams collaborated to lead this consultation and analyse the findings.
With 5,544 survey responses and 195 written submissions, alongside webinars, public events, and stakeholder meetings, we compiled a comprehensive report. Our analysis played a key role in NHS England’s decision to stop prescribing certain ineffective treatments, while altering others based on stakeholder input, ultimately benefiting patients and reducing costs.
Read the full case study
Further information
If you would like more information about our services, you can contact us on mlcsu.medicines-management@nhs.net